A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive disorder
一项旨在验证安索法辛（LY03005）治疗重度抑郁症的疗效和安全性的3期、多中心、双盲、随机、安慰剂对照临床试验
期刊:Translational Psychiatry
影响因子:6.2
doi:10.1038/s41398-023-02435-0
Mi, Weifeng; Di, Xiaolan; Wang, Yiming; Li, Huafang; Xu, Xiufeng; Li, Lehua; Wang, Huaning; Wang, Guoqiang; Zhang, Kerang; Tian, Feng; Luo, Jiong; Yang, Chanjuan; Zhou, Yunfei; Xie, Shiping; Zhong, Hua; Wu, Bin; Yang, Dong; Chen, Zhenhua; Li, Yi; Chen, Jindong; Lv, Shuyun; Yi, Qizhong; Jiang, Zhiwei; Tian, Jingwei; Zhang, Hongyan
